4 Therapeutic utility of EC359 for targeting LIFR signaling in Type II endometrial cancer

• Main Authors: Nicole M. Spencer (Author), Lois Randolph (Author), Alondra L. Rodriguez Sanchez (Author), Hareesh B. Nair (Author), Edward R. Kost (Author), Ratna K. Vadlamudi (Author), Suryavathi Viswanadhapalli (Author)
• Formato: Livro
• Publicado em: Elsevier, 2023-06-01T00:00:00Z.
• Assuntos: article
• Acesso em linha: Connect to this object online.

Objectives: Endometrial cancer is the most common gynecologic malignancy in women. Of the two histological subtypes of endometrial cancer described, Type II tumors are biologically more aggressive and convey a less favorable prognosis when compared to Type I tumors. Novel therapeutics for treatment...